We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Smith & Nephew Plc | SN. | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -3.00 | -0.27% | 1,122.00 | 16:35:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1,123.00 | 1,121.00 | 1,132.00 | 1,122.00 | 1,125.00 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 27/02/2024 | Final | USD | 0.231 | 28/03/2024 | 02/04/2024 | 22/05/2024 |
| 03/08/2023 | Interim | USD | 0.144 | 05/10/2023 | 06/10/2023 | 01/11/2023 |
| 21/02/2023 | Final | USD | 0.231 | 30/03/2023 | 31/03/2023 | 17/05/2023 |
| 28/07/2022 | Interim | USD | 0.144 | 29/09/2022 | 30/09/2022 | 26/10/2022 |
| 22/02/2022 | Final | USD | 0.231 | 31/03/2022 | 01/04/2022 | 11/05/2022 |
| Top Posts |
|---|
Posted at 18/7/2024 15:26 by foreverbull Are you meaning to say he could have bought SN shares which would have helped him make (or loose) more money? |
Posted at 04/7/2024 08:46 by foreverbull Smith & Nephew Snats (SN) has released an update.Smith & Nephew PLC has notified a change in major holdings, with Norges Bank crossing the threshold on June 28, 2024, now holding a total of 3.054% voting rights. This significant financial activity, reported on July 3, 2024, reflects a combination of voting rights attached to shares and financial instruments, amounting to over 26 million voting rights within the medical equipment manufacturer. |
Posted at 07/6/2024 07:54 by socionomics The good news for SN investors is that we're heading into Wave 5, so we should break the £20 high in due course. The bad news is that's a 5-6 year move. Might be a little too boring for many, but for me it's an easy SIPP play.DYOR as always. |
Posted at 02/5/2024 12:24 by justiceforthemany The P/E discrepancy to peers like Stryker is stark.SN at 15x Stryker near 35x CEO roasted at the AGM yesterday. |
Posted at 30/4/2024 05:17 by alotto Smith and nephew has always been way overpriced. Even at the current level still seems overpriced. The dividend payout is below what you get from a saving account and the prospect for growth is just about meh.The share price should be half as much to yield a healthy dividend of 5-6%. I would buy only with the wish of seeing the share price back to historical levels but I can't put any weight behind my wish especially with the debt it carries and the rates. |
Posted at 06/3/2024 13:38 by cerrito Interested to read this in Citywirequote he market has an ‘unconscious bias’ against Smith & Nephew (SN) and always assumes the worst about the medical technology company, says Liberum. Analyst Seb Jantet retained his ‘buy’ recommendation and target price of £12.85 on the Citywire Elite Companies AA-rated provider of hip and knee implants, which rose 0.3% to £10.46 on Tuesday. ‘We are slightly perplexed by the market’s reaction to Smith & Nephew’s full-year results,’ Jantet said. ‘Trading was in line and there was a solid guide for full year 2024. And while the initial share price reaction was positive, the shares fell sharply over the next few days. ‘Understandabl He added that ‘both the revenue and margin guides are achievable’ and said the ‘discount to peers is too high’. |
Posted at 13/10/2023 12:43 by essentialinvestor Might be worth looking at what the CEO does.. ?His large sales at £12.74 and £12.78 now look very astute. 5 different CEO's in 10 years, eh A rating of 16 X forward looks more than fair for SN. in a post ZIRP world. The market might see it differently, but that's how it looks to me. |
Posted at 12/10/2023 14:58 by essentialinvestor Laurence, part of the issue is arguably their main competitors growing strongerv SN over the last decade. This may account for some of SN's weaker metrics. While a bid can't be ruled out, it has been mentioned as a takeover candidate for decades. If you go back 10 years, this was a high margin business with low gearing and a prodigious cash generator. Those bullish on SN may say that's now reflected in the current share price, however circa 2013, at approx £8 plus a share you were buying at the time a great business. |
Posted at 12/10/2023 09:01 by essentialinvestor How are margins stable?, trading profit margin registered a hefty fall at the H1 to15.3%. For years SN had trading profit margins in excess of 20%, for a few years around 24/25%. Margins began a multi year decline around 2015/16 (from memory) and despite multiple CEO's since, each with a new refreshed strategy to improve business performance, results have arguably been sadly lacking. Margin compression leading to reduced free cash flow is central to the bearish case on SN. |
Posted at 05/10/2023 08:27 by pugugly Ex Dividend today - 11.915p |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
